Clinical Trial Update: Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). [Phase 3]

View source ↗

Summary

Phase 3 trial comparing sotorasib (AMG 510) against docetaxel in KRAS G12C-mutated advanced/metastatic non-small cell lung cancer; results were posted in May 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• sotorasib (sotorasib)

Snippet

Sponsor: Amgen | Conditions: KRAS p, G12c Mutated /Advanced Metastatic NSCLC | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-05-10